Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AstraZeneca
Biotech
Novo Holdings-backed biotech raises $205M to fill gout care gap
Crystalys and its team of 10 people—and growing—is pushing ahead in hopes of filling the treatment gap for patients with gout.
Gabrielle Masson
Sep 30, 2025 8:00am
Pharma execs grilled by UK lawmakers over R&D pullback
Sep 16, 2025 12:27pm
AZ pauses $271M UK expansion as British backtrack continues
Sep 12, 2025 2:44pm
ABPI releases life sci competition report as UK investment lags
Sep 10, 2025 5:30pm
Fierce Pharma
Editor's Corner—Summit must submit to Big Pharma, stat
Sep 10, 2025 2:50pm
AstraZeneca gears up for baxdrostat FDA filing after ph. 3 win
Sep 1, 2025 6:13am